Pharmaceutical Technology

APRIL 6, 2023

Moderna has announced that its cancer vaccine mRNA-4157/V940 along with Keytruda secured the European Medicines Agency (EMA) Priority Medicines (PRIME) scheme designation for the adjuvant treatment of high-risk stage III/IV melanoma patients after complete resection.

Vaccines 98

Vaccines Labelling Immunity Immunization 98

Pharmaceutical Technology

JANUARY 31, 2023

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Moderna ’s investigational mRNA vaccine candidate, mRNA-1345, for respiratory syncytial virus (RSV) in adult patients. The investigational mRNA-1345 vaccine uses the same lipid nanoparticles (LNPs) that are also used in the Moderna Covid-19 vaccines.

Vaccines 72

Vaccines Communication 72

Pharmaceutical Technology

APRIL 25, 2023

As the prophylactic landscape for malaria has changed in recent years with vaccine approvals, major issues still remain with ensuring access in remote communities. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements. The Mosquirix vaccine contains two vials.

Vaccines 69

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 69

pharmaphorum

AUGUST 25, 2022

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular. . Tune in to learn more. . You can listen to episode 58 of the? Podbean. .

Vaccines 52

Vaccines Immunity Immunization 52

Pharmaceutical Technology

NOVEMBER 30, 2022

in a project agreement from the US government for developing self-amplifying RNA (saRNA) vaccine technology against advanced and emergent viral threats. Development of vaccines to Phase I trials under the five-year $59m prototype project comprises additional $28.4m in milestone payments. By Cytiva Thematic.

Vaccines 59

Vaccines Communication 59

pharmaphorum

MARCH 2, 2021

The COVID-19 pandemic brought life-changing disruptions to people around the world and has turned the typical vaccine R&D process on its head. Download the Full Event Guide here. Overcome immunogenicity challenges and design safe and efficacious vaccine formulations. Register online here to take part.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

MAY 4, 2023

After a winter marked by a rise in hospitalisations due to the RSV, the FDA has granted its first approval for an Respiratory Syncytial Virus (RSV) vaccine to GSK’s Arexvy for adults ages 60 years and above. This vaccine specifically prevents RSV-related lower respiratory tract disease (LRTD).

Vaccines 64

Vaccines Communication Immunity Immunization 64

Putting Patients First Blog

JULY 7, 2023

The NHC Releases Research Brief and Infographic on COVID-19 Vaccine Technology and Hesitancy July 7, 2023 By: Lillian L.Q. Witting, MPH, Coordinator, Research, Education, and Programs Vaccinations are a major accomplishment of the 20th century. Though the COVID-19 pandemic has taken a turn, it is still present in our everyday lives.

Vaccines 52

Vaccines Immunity Immunization 52

Pharmaceutical Technology

MARCH 1, 2023

Oragenics and Inspirevax have signed a license agreement to develop the former’s lead intranasal vaccine candidate for Covid-19, NT-CoV2-1. As part of the exclusive international agreement, Oragenics agreed to pursue the vaccine development with the new BDX301 intranasal mucosal adjuvant of Inspirevax.

Vaccines 52

Vaccines Communication 52

Pharmaceutical Technology

APRIL 24, 2023

Since then, the field of nanomedicine has steadily progressed to reach high points such as the successful use of nanotechnology to deliver messenger RNA (mRNA)-based Covid-19 vaccines. In the case of most mRNA vaccines, a lipid nanoparticle-based approach was chosen due to its ability to protect the mRNA in the body and prevent degradation.

Vaccines 59

Vaccines Immunity Immunization Medical Schools 59

Pharmaceutical Technology

DECEMBER 13, 2022

To develop a vaccine and then get as many people vaccinated as quickly as possible. Advanced monitoring and analysis technology has enabled more than 13 billion COVID-19 vaccinations to be distributed worldwide to date. Before the COVID-19 pandemic, 25-50% of vaccines were wasted due to cold chain issues. Free Report.

Vaccines 52

Vaccines Communication Documentation 52

Pharmaceutical Technology

MAY 30, 2023

million government grant from the Flanders Innovation & Entrepreneurship (VLAIO) agency that will be used to fuel the company’s vaccine platform, per a 30 May announcement. The company’s prophylactic yellow fever vaccine is part of its plasmid-launched live attenuated virus (PLLAV) platform. AstriVax has received a €2.5

Vaccines 52

Vaccines Communication 52

pharmaphorum

OCTOBER 13, 2022

In this episode of the pharmaphorum podcast series, Dr Paul Tunnah chats with Jeff Baxter, CEO of VBI Vaccines and Lee Taurman, executive vice president full service commercial at Syneos Health. Jeff Baxter – President and CEO, VBI Vaccines. About the interviewees. Whitman School of Management at Syracuse University.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

MAY 12, 2023

BioNTech has ended its research collaboration with Matinas after its oral mRNA vaccine failed to demonstrate preclinical activity. Whilst BioNTech has shelved its oral mRNA vaccine project, shares were up this week following promising early results of a personalised mRNA vaccine for pancreatic cancer.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

NOVEMBER 15, 2022

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This also has clear advantages in healthcare settings, particularly when it comes to vaccines. In general, a prefilled syringe is clearly preferred for vaccines.”. A new challenge .

Packaging 52

Packaging Vaccines Dosage Compounding 52

Pharmacy Joe

OCTOBER 14, 2020

In this episode, I’ll discuss why the quadrivalent meningococcal vaccine was used as a control for a COVID-19 vaccine. Episode 548: Why was the quadrivalent meningococcal vaccine used as a control for a COVID-19 vaccine? The delivery of this spike protein then causes the immunogenicity to the virus to develop.

Vaccines 40

Vaccines Inpatient 40

Pharmacy Joe

FEBRUARY 24, 2021

In this episode, I’ll discuss the CDC Recommendations if a patient develops COVID-19 before receiving the 2nd vaccine dose. Patients who get COVID-19 before their 2nd vaccine dose and are treated with a monoclonal antibody, and 2. This guidance also applies to people who get COVID-19 before getting their second dose of vaccine.

Vaccines 40

Vaccines Inpatient Immunity Immunization 40

Pharmacy Joe

SEPTEMBER 23, 2021

In this episode, I’ll discuss a possible syndrome that might herald vaccine-induced immune thrombotic thrombocytopenia. Episode 646: Does vaccine-induced immune thrombotic thrombocytopenia have a “pre-VITT syndrome” ? All 11 patients presented with severe headache 5 to 18 days after adenovirus vector vaccination.

Immunity 40

Immunity Immunization Vaccines Inpatient 40

Pharmaceutical Technology

SEPTEMBER 8, 2022

The information contained within the download document is designed for pharmaceutical executives, developers, research scientists and associates, regulatory solutions consultants, and any other individual involved in API biologics production in the pharmaceutical industry.

Vaccines 40

Vaccines Packaging Documentation Labelling 40

Pharmaceutical Technology

MARCH 24, 2023

Since the first human administration of the Bacillus Calmette-Guérin vaccine in 1921, no one has been able to successfully follow the vaccine’s path to become the next approved vaccine to tackle tuberculosis (TB). However, as the TB-related death toll remains high, the global need for another vaccine is steadily rising.

Vaccines 64

Vaccines Health and Personal Care Stores Immunity Immunization 64

Pharmaceutical Technology

MAY 1, 2023

After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May. What incentivises a country to cover a vaccine?

Vaccines 52

Vaccines Nursing Homes Communication Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

Digital Pharmacist

SEPTEMBER 27, 2023

Does Medicare Part D cover vaccinations? Part D plans will cover most vaccines, except for those covered in Part B. Download these FAQs in an easy-to-print flyer format that you can distribute to your patients. If a medication is not on the formulary, patients can request an exception, pay out of pocket, or file an appeal.

Vaccines 98

Vaccines Pharmacy Management 98

Pharma Marketing Network

APRIL 13, 2025

Link educational pages to prescribing information, safety updates, and downloadable resources. MOA of Enbrel) or recent studies must include citations, downloadable PDFs, and charts that support decision-making. Brands supporting vaccination awareness or community clinics benefit from optimizing location-specific content.

Diabetes 52

Diabetes Dosage Vaccines 52

Pharmaceutical Technology

MARCH 23, 2023

China’s National Medical Products Administration (NMPA) has granted emergency use authorisation (EUA) for CSPC Pharmaceutical Group’s messenger RNA (mRNA) vaccine, SYS6006, to treat Covid-19. With this regulatory approval, CSPC Pharmaceutical is claimed to be the first company to receive approval for providing an mRNA vaccine in the country.

Vaccines 52

Vaccines Communication 52

Pharmaceutical Technology

MARCH 22, 2023

Among other things, supply chain optimisation, maintaining access to affordable vaccines, and supporting innovation for unmet clinical needs will be the discussion topics, she adds. Download the full report to understand what to expect and how to align your strategies for success. Please check your email to download the Report.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

Pharmaceutical Technology

MARCH 29, 2023

Pharmaron is receiving a £151 million investment in capital to support the growth of operations in Liverpool, quadrupling production capacity for gene therapy and vaccine components. Download the full report to understand what to expect and how to align your strategies for success. Please check your email to download the Report.

Communication 110

Communication Vaccines 110

RX Note

APRIL 12, 2025

Downloaded content can be accessed offline. LactRx LactRx by MotherToBaby is a free app designed to provide current information regarding the use of medications, vaccines, diagnostic agents and drugs of misuse while breastfeeding. However, the free version lacks disease information, available in collaboration with BMJ Best Practice.

Health and Personal Care Stores 52

Health and Personal Care Stores Compounding Packaging Hospitals 52

The Digital Apothecary

AUGUST 15, 2017

For instance, a physical location offers the ability to offer vaccinations and filling of same-day needed prescriptions (such as antibiotics, pain medications, etc.) Download Image. Each has pros and cons of services. after seeing a doctor visit. So with that, I welcome any thoughts or comments.

Mail-Order Pharmacies 130

Mail-Order Pharmacies Insurance Coverage and Processing Health and Personal Care Stores Medication Dispensing 130

Pharmaceutical Technology

MAY 22, 2023

There is a stark difference in favour of the UK biotech ecosystem in terms of expenses compared to the US biotech ecosystem, and specifically the New England region, says Mark Leuchtenberger, CEO of Oxford-based company SpyBiotech, a vaccine developer that plans to study a human cytomegalovirus infection vaccine in H2 2023.

Vaccines 111

Vaccines Compounding Communication 111

Pharmaceutical Technology

DECEMBER 8, 2022

Prefilled syringes are increasingly being recognised as the safest method of packaging injectable drugs, and they offer a number of advantages when administering vaccines specifically. Please check your email to download the Whitepaper. Lessons from the Pandemic: Building a Better Prefilled Syringe. By Datwyler. United Kingdom.

Packaging 98

Packaging Vaccines Communication Drug Development 98

Pharmaceutical Technology

JUNE 13, 2023

Common treatment options for the condition include bladder removal surgery, chemotherapy and/or administration of the BCG vaccine in the bladder. According to GlobalData, Adstiladrin is one of six therapies approved for the treatment of non-muscle invasive bladder cancer in the US, including two BCG vaccines.

Vaccines 98

Vaccines Chemotherapy Communication 98

Pharmaceutical Technology

MARCH 20, 2023

The mRNA technology that enabled the largest and fastest vaccine rollout in history is the tip of the innovation iceberg. Poolberg Pharma is deploying AI algorithms on early-stage clinical data to prioritise and reposition vaccine candidates for respiratory syncytial virus. Download the whitepaper to find out more.

Vaccines 90

Vaccines Communication Hospitals 90

Drug Channels

FEBRUARY 22, 2022

Those who preorder will receive a download link before March 15. CLICK HERE to download a free pre-publication overview. Download a free report overview for more details. We are providing you with the opportunity to preorder this thoroughly updated, revised, and expanded 2022 edition at special discounted prices.

Specialty Pharmacies 96

Specialty Pharmacies Drug Pricing Biosimilars Vaccines 96

Pharmaceutical Technology

MAY 5, 2023

The value of real-time data Amid unprecedented instability in lockdown-stricken supply chains, digital transformation company Controlant helped to safely deliver more than 5 billion COVID-19 vaccines. Download the whitepaper on this page to find out more. Download the whitepaper to find out more.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 59

Digital Pharmacist

JANUARY 25, 2024

Quick Tip: Link to your appointment scheduler using the “booking” feature for vaccinations or consultations. Click here for a printable PDF version that you can download to complete your Google Business Profile setup. With these features, you can create bookings , post updates , add products , or address FAQs to enhance your profile.

Customer Service 94

Customer Service Pharmacy Management Vaccines 94

Express Pharma

JUNE 12, 2024

Covid-19 promoted India to the centre stage of global vaccine export as the consumerisation of health providing an impetus for vaccines and prompt approvals. Big pharma companies are engaging in divestitures to accumulate prolific dry powder from freed-up capital permitting investment in their core focus areas.

Generic Medicine 105

Generic Medicine Vaccines Diabetes Immunity 105